Compare CTMX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTMX | PMT |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 977.1M | 1.2B |
| IPO Year | 2015 | N/A |
| Metric | CTMX | PMT |
|---|---|---|
| Price | $3.83 | $10.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | $12.10 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 3.4M | 1.0M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $76,201,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.61 | $1.55 |
| P/E Ratio | $22.58 | ★ $12.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.72 | $10.77 |
| 52 Week High | $8.21 | $13.80 |
| Indicator | CTMX | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 30.58 |
| Support Level | $3.39 | N/A |
| Resistance Level | $3.91 | $12.85 |
| Average True Range (ATR) | 0.25 | 0.26 |
| MACD | -0.04 | -0.15 |
| Stochastic Oscillator | 2.86 | 0.32 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.